Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
214 hedge funds and large institutions have $3.44B invested in Inari Medical, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 90 increasing their positions, 62 reducing their positions, and 18 closing their positions.
133% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 18
69% more call options, than puts
Call options by funds: $26.4M | Put options by funds: $15.7M
45% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 62
11% more funds holding
Funds holding: 192 → 214 (+22)
6% more capital invested
Capital invested by funds: $3.24B → $3.44B (+$200M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$121M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$40.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.1M |
| 4 |
Millennium Management
New York
|
+$29.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$26.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$12M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$9.48M |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$9.38M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.34M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.22M |
NARI Hedge Fund Activity: Q1 2022 in Review
214 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q1 2022, worth a combined $3.44B — up 6.2% from $3.24B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new NARI positions and 18 closed out — a net gain of 24 holders — while 90 added to existing stakes and 62 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $121M. The largest seller was Credit Suisse, cutting an estimated $12M.
- 214 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q1 2022, up from 192 in Q4 2021.
- Funds reported $3.44B of Inari Medical, Inc. Common Stock stock for Q1 2022, up 6.2% quarter-over-quarter.
- 42 funds opened new Inari Medical, Inc. Common Stock positions in Q1 2022 and 18 closed out, a net change of +24 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q1 2022 was Wellington Management Group, an estimated $121M added.
- The largest Inari Medical, Inc. Common Stock seller in Q1 2022 was Credit Suisse, an estimated $12M sold.
Based on aggregated 13F filings for Q1 2022.